In the Journals

Mai – June 2019 High-amylose wheat lowers the postprandial glycemic response to bread in healthy adults: A randomized controlled crossover trial.The Journal of Nutrition The moderating effect of childhood disadvantage on the associations between smoking and occupational exposure and lung function: A cross sectional analysis of the UK Household Longitudinal Study (UKHLS) BMC Public Health …

Aspirin in colorectal cancer

The timeline of Acetylsalicylic Acid Aspirin (Acetylsalicylic Acid), who started its life as an ordinary headache tablet turned out to be an effective blood thinner and established itself on the cardiology shelves of our pharmacies. If the outcome of recent studies is to be confirmed, Acetylsalicylic Acid will soon be prescribed by oncologists. Encouraging outcomes Evidence …

Ketamine to treat depression

There is a new light shining into the corner of treatment-resistant depression: in the form of a drug called Ketamine. This substance, not new to the medical world, is thought to have a rapid effect in clinical depression and could become a life-saver for people with severe suicidal depression. The drug has hallucinogenic and pain …

China to accelerate drug approval

According to recent news China is reporting that it intends to accelerate the approval process for new medication by accepting the data from international clinical trials. This is obviously great news for many patients in need of new generation drugs such as immunotherapy. By adopting this more open approach, the world’s second-largest drug market is …

No Benefits of low-dose Oxygen during Acute Stroke

To give or not to give Oxygen In case of an emergency and if in any doubt, give the patient oxygen. This first aid manoeuvre is also part of a knee-jerk when attending to an acute cerebrovascular accident. To protect brain tissue from hypoxia with continuous oxygen during the acute phase of a cerebrovascular accident …

Pembrolizumab – immunotherapy for gastric cancer

After encouraging results in treating melanoma, lung and kidney, immunotherapy enters the realm of gastric malignancies. The FDA has approved Pembrolizumab, (Keytruda) by Merk, for use as a third-line treatment for locally advanced or metastatic adenocarcinoma of the stomach and gastro-oesophageal junction that express programmed death receptor-ligand 1 (PD-L1). Immunotherapy tries to elicit the mechanisms how …

encouraging Study results for Venetoclax

Abbvie is coming up with some encouraging news from their phase III study evaluating the efficacy and safety of Venetoclax in combination with Mabthera/Rituxan compared to Bendamustine Venetoclax or in brand name terms: Venclexta in the USA and Venclyxto in Europe, is an oral treatment consisting of a small molecule that, highly selectively, inhibits the …

World Sepsis Day 2017

WHO calls for prevention of the life-threatening condition, especially for maternal and neonatal sepsis: 12 September 2017: Still today, Sepsis presents as a life-threatening condition. It can arise when the body’s response to infection causes injury to its tissues and organs. Infections often complicate underlying diseases; sepsis is a final common pathway leading to death …